Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0783
    -0.0010 (-0.10%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2626
    +0.0004 (+0.03%)
     
  • USD/JPY

    151.4320
    +0.0600 (+0.04%)
     
  • Bitcoin USD

    70,843.05
    +1,521.93 (+2.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,337.85
    +169.78 (+0.42%)
     

Athenahealth Explores Strategic Alternatives As CEO Steps Down

Amid a storm of sexual misconduct allegations against its top executive and a takeover attempt by Elliott Management Corp., Athenahealth, Inc (NASDAQ: ATHN) announced Wednesday the immediate resignation of Jonathan Bush as president and CEO and the exploration of strategic alternatives, including a potential sale or merger.

The board also appointed Jeff Immelt, former CEO of General Electric Company (NYSE: GE), as executive chairman.

Why It’s Important

Athenahealth investors rode waves of volatility this year, with the stock fluctuating between $115 and $153. The latest management changes help rid the company of a PR sore spot and, as the board says, position Athenahealth to capitalize on its healthcare tech platform.

What’s Next

Athenahealth has begun a search process to select a new CEO, and it confirmed no announcements will be made regarding a merger unless the board has approved a transaction.

According to Elliott, the firm has received interest from other potential buyers.

The stock was halted in Wednesday's pre-market session. Shares re-opened at 9:50 a.m. ET, trading higher by 6 percent at $160.33 at time of publication.

Related Links:

Analyst: When Americans Sneeze, Teladoc And Athenahealth Profit

Elliott Management Makes 0-Per-Share Takeover Offer For Athenahealth

See more from Benzinga

© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement